Leflunomide Mylan 10 mg

DRUG2 trials

Sponsors

Universitair Medisch Centrum Utrecht, Universitair Medisch Centrum Groningen

Conditions

polymyalgia rheumaticaprimary Sjögren's Syndrome

Phase 2

Leflunomide and Hydroxychloroquine combination therapy for primary Sjögren’s Syndrome; RepurpSS-II study

CompletedCTIS2024-510904-36-00

Universitair Medisch Centrum Utrechtprimary Sjögren's Syndrome

Start: 2021-10-12End: 2025-06-03Target: 52Updated: 2024-06-11

Phase 3

Leflunomide in PMR; A multicenter randomized placebo controlled treatment study of Leflunomide in polymyalgia rheumatica

Not yet recruitingCTIS2024-514210-12-00

Universitair Medisch Centrum Groningenpolymyalgia rheumatica

Target: 94Updated: 2024-08-12